There is a general assumption that it is now time for more translational research and less basic research. Science policy leaders have sent mixed signals and the community has responded by submitting more grant applications focused on translational or applied research. Nothing could be more treacherous, because to develop innovative therapies we must more fully understand the complexities of biology, a goal requiring more, not less, basic science.
Keywords: NIH; basic science; funding; precision medicine; science policy.
Copyright © 2015 Elsevier Ltd. All rights reserved.